Daan Gene Co., Ltd. (SHE:002030)

Daan Gene Statistics

Total Valuation

Daan Gene has a market cap or net worth of CNY 8.86 billion. The enterprise value is 8.33 billion.

Market Cap	8.86B
Enterprise Value	8.33B

Important Dates

The next estimated earnings date is Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Daan Gene has 1.40 billion shares outstanding. The number of shares has decreased by -4.97% in one year.

Current Share Class	1.40B
Shares Outstanding	1.40B
Shares Change (YoY)	-4.97%
Shares Change (QoQ)	-2.48%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	6.42%
Float	934.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.57
PB Ratio	1.11
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	35.50
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.77
EV / Sales	10.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2,767.17

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.01.

Current Ratio	3.06
Quick Ratio	1.86
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-35.61
Interest Coverage	-109.15

Financial Efficiency

Return on equity (ROE) is -7.09% and return on invested capital (ROIC) is -5.46%.

Return on Equity (ROE)	-7.09%
Return on Assets (ROA)	-4.83%
Return on Invested Capital (ROIC)	-5.46%
Return on Capital Employed (ROCE)	-9.04%
Revenue Per Employee	442,475
Profits Per Employee	-325,985
Employee Count	1,730
Asset Turnover	0.08
Inventory Turnover	2.84

Taxes

Income Tax	-84.47M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.90% in the last 52 weeks. The beta is 0.34, so Daan Gene's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+13.90%
50-Day Moving Average	6.36
200-Day Moving Average	6.32
Relative Strength Index (RSI)	51.85
Average Volume (20 Days)	19,293,029

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daan Gene had revenue of CNY 765.48 million and -563.95 million in losses. Loss per share was -0.40.

Revenue	765.48M
Gross Profit	151.63M
Operating Income	-737.27M
Pretax Income	-672.86M
Net Income	-563.95M
EBITDA	-402.61M
EBIT	-737.27M
Loss Per Share	-0.40

Balance Sheet

The company has 887.04 million in cash and 107.18 million in debt, with a net cash position of 779.86 million or 0.56 per share.

Cash & Cash Equivalents	887.04M
Total Debt	107.18M
Net Cash	779.86M
Net Cash Per Share	0.56
Equity (Book Value)	7.99B
Book Value Per Share	5.52
Working Capital	1.93B

Cash Flow

In the last 12 months, operating cash flow was 249.43 million and capital expenditures -252.44 million, giving a free cash flow of -3.01 million.

Operating Cash Flow	249.43M
Capital Expenditures	-252.44M
Free Cash Flow	-3.01M
FCF Per Share	-0.00

Margins

Gross margin is 19.81%, with operating and profit margins of -96.31% and -73.67%.

Gross Margin	19.81%
Operating Margin	-96.31%
Pretax Margin	-87.90%
Profit Margin	-73.67%
EBITDA Margin	-52.60%
EBIT Margin	-96.31%
FCF Margin	n/a

Dividends & Yields

Daan Gene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.97%
Shareholder Yield	4.97%
Earnings Yield	-6.37%
FCF Yield	-0.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 19, 2021. It was a forward split with a ratio of 1.6.

Last Split Date	May 19, 2021
Split Type	Forward
Split Ratio	1.6

Scores

Daan Gene has an Altman Z-Score of 5.72 and a Piotroski F-Score of 3.

Altman Z-Score	5.72
Piotroski F-Score	3